Moreover, the ratio of CD4+ T cells and CD8+ T cells near proliferating tumor cells in BRCA1/2-deficient tumors is positively correlated with patient prognosis, suggesting that the coordination of immune surveillance through the spatial connection of cells improves the prognosis of patients [38]. This evidence concerns the gene CD4 and neoplasm.